DOCPHARMA
ActiveSummary
DOCPHARMA has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36.6m and a net result of €581,444. Equity remains stable across the filed fiscal years (±1.4% per year). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability41▼-3
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000,000 at 30 days acceptable
short-term debt: 0% of total assets, and 24.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
75.8%
Return on assets
1.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
24 d early
2024
34 d early
2023
34 d early
2022
20 d early
2021
24 d early
2020
18 d early
2019
22 d early
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 7 accounts on average 25 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 7 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€581,444▼ 51.8%
2024 · €1.2m
Working capital
€48.2m▲ 2.2%
2024 · €47.2m
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€473,544▼ 12.5%-€433,182▲ 8.5%-€464,564▼ 7.2%-€469,053▼ 1.0%-€476,575▼ 1.6%
Net result-€466,245▼ 12.7%€1.2m€788,648▼ 36.2%€1.2m▲ 53.0%€581,444▼ 51.8%
Equity€32.7m▼ 1.4%€34.0m▲ 3.8%€34.8m▲ 2.3%€36.0m▲ 3.5%€36.6m▲ 1.6%
Total assets€47.8m=€44.3m▼ 7.4%€45.5m▲ 2.8%€47.2m▲ 3.6%€48.2m▲ 2.2%
Debt€15,338▲ 559%€14,466▼ 5.7%€27,707▲ 91.5%€12,465▼ 55.0%€13,685▲ 9.8%
Working capital€47.8m=€44.3m▼ 7.4%€45.5m▲ 2.8%€47.2m▲ 3.6%€48.2m▲ 2.2%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €476,575 in 2025 against €469,053 in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €48.2m
Equity
€36.6m ▲ 1.6%
Provisions
€11.6m ▲ 4.0%
Debt
€13,685 ▲ 9.8%
Debt's share of the balance-sheet total stays at 0.0%.
Key figures and ratios
Debt to equity
0.00▲
2024 · 0.00
ROE
1.6%▼
2024 · 3.4%
ROA
1.2%▼
2024 · 2.6%
Debt ≤ 1 year
€13,685▲
2024 · €12,465
A ratio outside any meaningful range has been withheld (balance sheet total €48.2m, equity €36.6m).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 491 companies that looked in July 2024 the way this one looks now, 0.8% went bankrupt within 24 months and 96% are still going.
- Large
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
0.8%
went bankrupt
3.3%
stopped otherwise
96%
still going
For this company itself Checked computes a bankruptcy probability of 0.5% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 491 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | - | €36,613 | €3,974 | - | - | - |
| Other operating income74 | - | €36,613 | €3,974 | - | - | - |
| Operating charges60/66A | €473,544 | €469,795 | €468,538 | €469,053 | €476,575 | ▲ 1.6% |
| Services and other goods61 | €21,913 | €18,163 | €16,764 | €16,184 | €24,943 | ▲ 54.1% |
| Remuneration, social security and pensions62 | - | - | €142 | - | - | - |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €451,631 | €451,632 | €451,632 | €452,869 | €451,632 | ▼ 0.3% |
| Operating profit (loss)9901 | -€473,544 | -€433,182 | -€464,564 | -€469,053 | -€476,575 | ▼ 1.6% |
| Financial income75/76B | - | €1.7m | €1.3m | €1.7m | €1.1m | ▼ 37.6% |
| Recurring financial income75 | €8,636 | €8,808 | €1.3m | €1.7m | €1.1m | ▼ 37.6% |
| Income from current assets751 | €8,636 | €8,808 | €1.3m | €1.7m | €1.1m | ▼ 37.6% |
| Other financial income752/9 | - | - | €0 | €0 | €0 | - |
| Non-recurring financial income76B | - | €1.7m | - | - | - | - |
| Financial charges65/66B | €1,337 | €1,494 | €1,849 | €1,880 | €764 | ▼ 59.4% |
| Recurring financial charges65 | €1,337 | €1,494 | €1,849 | €1,880 | €764 | ▼ 59.4% |
| Other financial charges652/9 | €1,337 | €1,494 | €1,849 | €1,880 | €764 | ▼ 59.4% |
| Profit (loss) for the period before taxes9903 | -€466,245 | €1.2m | €802,184 | €1.2m | €581,444 | ▼ 52.6% |
| Income taxes67/77 | - | - | €13,537 | €20,352 | - | - |
| Taxes670/3 | - | - | €13,537 | €20,352 | - | - |
| Profit (loss) for the period9904 | -€466,245 | €1.2m | €788,648 | €1.2m | €581,444 | ▼ 51.8% |
| Profit (loss) for the period to be appropriated9905 | -€466,245 | €1.2m | €788,648 | €1.2m | €581,444 | ▼ 51.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €47.8m | €44.3m | €45.5m | €47.2m | €48.2m | ▲ 2.2% |
| Formation expenses20 | - | €0 | €0 | €0 | €0 | - |
| Fixed assets21/28 | - | €0 | €0 | €0 | €0 | - |
| Tangible fixed assets22/27 | - | €0 | €0 | €0 | €0 | - |
| Furniture and vehicles24 | - | €0 | €0 | €0 | €0 | - |
| Financial fixed assets28 | - | €0 | €0 | €0 | €0 | - |
| Affiliated companies280/1 | - | €0 | €0 | €0 | €0 | - |
| Participating interests280 | - | €0 | €0 | €0 | €0 | - |
| Current assets29/58 | €47.8m | €44.3m | €45.5m | €47.2m | €48.2m | ▲ 2.2% |
| Amounts receivable within one year40/41 | €47.8m | €44.2m | €45.5m | €47.2m | €48.2m | ▲ 2.2% |
| Other amounts receivable41 | €47.8m | €44.2m | €45.5m | €47.2m | €48.2m | ▲ 2.2% |
| Cash at bank and in hand54/58 | €50,485 | €49,432 | €0 | - | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €47.8m | €44.3m | €45.5m | €47.2m | €48.2m | ▲ 2.2% |
| Equity10/15 | €32.7m | €34.0m | €34.8m | €36.0m | €36.6m | ▲ 1.6% |
| Contributions10/11 | €83.3m | €83.3m | €83.3m | €83.3m | €83.3m | = |
| Profit (loss) carried forward14 | -€50.6m | -€49.3m | -€48.5m | -€47.3m | -€46.7m | ▲ 1.2% |
| Provisions and deferred taxes16 | €15.1m | €10.3m | €10.7m | €11.2m | €11.6m | ▲ 4.0% |
| Provisions for liabilities and charges160/5 | €15.1m | €10.3m | €10.7m | €11.2m | €11.6m | ▲ 4.0% |
| Other liabilities and charges164/5 | €15.1m | €10.3m | €10.7m | €11.2m | €11.6m | ▲ 4.0% |
| Amounts payable17/49 | €15,338 | €14,466 | €27,707 | €12,465 | €13,685 | ▲ 9.8% |
| Amounts payable within one year42/48 | €15,338 | €14,466 | €27,707 | €12,465 | €13,685 | ▲ 9.8% |
| Trade debts44 | €13,011 | €12,139 | €11,843 | €12,465 | €13,685 | ▲ 9.8% |
| Suppliers440/4 | €13,011 | €12,139 | €11,843 | €12,465 | €13,685 | ▲ 9.8% |
| Taxes, remuneration and social security45 | €2,327 | €2,327 | €15,864 | - | - | - |
| Taxes450/3 | €2,327 | €2,327 | €15,864 | - | - | - |
| Other amounts payable47/48 | - | €0 | €0 | €0 | €0 | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€466,245 | €1.2m | €788,648 | €1.2m | €581,444 | ▼ 51.8% |
| Operating cash flow (approximation) | -€466,245 | €1.2m | €788,648 | €1.2m | €581,444 | ▼ 51.8% |
| Investment in fixed assets (approximation) | - | - | €0 | €0 | €0 | - |
| Change in cash | - | -€1,053 | -€49,432 | - | - | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
02-07
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Tom Renders3 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)
Permanent representative: Tom Renders3 facts ▸
- General meeting, 18-06-2026
- Auditor reappointment, Deloitte Bedrijfsrevisoren BV (statutory auditor)
- Permanent representative, Tom Renders (permanent representative)
2025
10-12
State Gazette act
Resignation: Matthew Salzmann (director)Appointment: Arun Narayan (director) · Mandate compensation · Power of attorney6 facts ▸
State Gazette act
Resignation: Matthew Salzmann (director)
Appointment: Arun Narayan (director) · Mandate compensation · Power of attorney6 facts ▸
- Shareholder decision, 25-11-2025
- Director resignation, Matthew Salzmann (director)
- Director appointment, Arun Narayan (director)
- Mandate compensation, Arun Narayan
- Power of attorney, Johan Lagae
- Power of attorney, Els Bruls
10-07
State Gazette act
Resignation: Vincent Verschraegen (director)Appointment: Tomasz Buczek (director) · Mandate compensation · Power of attorney6 facts ▸
State Gazette act
Resignation: Vincent Verschraegen (director)
Appointment: Tomasz Buczek (director) · Mandate compensation · Power of attorney6 facts ▸
- Shareholder decision, 24-06-2025
- Director resignation, Vincent Verschraegen (director)
- Director appointment, Tomasz Buczek (director)
- Mandate compensation, Tomasz Buczek
- Power of attorney, Johan Lagae
- Power of attorney, Els Bruls
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Liquidity doublescurrent ratio 3784.05
Current ratio from 1643.12 to 3784.05; short-term debt falls from €27,707 to €12,465.
27-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
21-03
State Gazette act
Resignation: Luis Birbuet (director)Appointment: Matthew Salzmann (director) · Mandate compensation · Power of attorney6 facts ▸
State Gazette act
Resignation: Luis Birbuet (director)
Appointment: Matthew Salzmann (director) · Mandate compensation · Power of attorney6 facts ▸
- General meeting, 28-02-2024
- Director resignation, Luis Birbuet (director)
- Director appointment, Matthew Salzmann (director)
- Mandate compensation, Matthew Salzmann
- Power of attorney, Johan Lagae
- Power of attorney, Els Bruls
2023
11-07
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)Power of attorney4 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)
Power of attorney4 facts ▸
- General meeting, 28-06-2023
- Auditor reappointment, Deloitte Bedrijfsrevisoren BV (statutory auditor)
- Power of attorney, Johan Lagae
- Power of attorney, Els Bruls
11-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Back to profitnet €1.2m
Net result €1.2m after 4 loss-making years.
07-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
Show earlier events
2021
31-12
Financial
Weakest financial yearnet -€466,245
Net result drops to -€466,245, the lowest in the series; recovery starts the following year.
13-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
14-04
State Gazette act
Resignation: José Cotarelo (director)Appointment: Luis Birbuet (director) · Mandate compensation6 facts ▸
State Gazette act
Resignation: José Cotarelo (director)
Appointment: Luis Birbuet (director) · Mandate compensation6 facts ▸
- General meeting, 30-03-2021
- Director resignation, José Cotarelo (director)
- Director appointment, Luis Birbuet (director)
- Mandate compensation, Luis Birbuet
- Board composition, Vincent Verschraegen (director)
- Board composition, Luis Birbuet (director)
2020
31-12
Financial
Liquidity times 6current ratio 20546.75
Current ratio from 3553.83 to 20546.75; short-term debt falls from €13,447 to €2,327.
14-07
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)Power of attorney3 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)
Power of attorney3 facts ▸
- General meeting, 18-06-2020
- Auditor reappointment, Deloitte Bedrijfsrevisoren
- Power of attorney, Joanna Bochner
09-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
09-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
08-02
State Gazette act
Resignations: Anthonius van 't Hullenaar (manager) and Maximilian von Wülfing (manager)Appointments: Vincent Verschraegen (manager) and Jose Cotarelo (manager) · Permanent representative: Vincent Verschraegen · Mandate compensation9 facts ▸
State Gazette act
Resignations: Anthonius van 't Hullenaar (manager) and Maximilian von Wülfing (manager)
Appointments: Vincent Verschraegen (manager) and Jose Cotarelo (manager) · Permanent representative: Vincent Verschraegen · Mandate compensation9 facts ▸
- General meeting, 20-12-2018
- Director resignation, Anthonius van 't Hullenaar (manager)
- Director resignation, Maximilian von Wülfing (manager)
- Director appointment, Vincent Verschraegen (manager)
- Director appointment, Jose Cotarelo (manager)
- Mandate compensation, Vincent Verschraegen
- Mandate compensation, Jose Cotarelo
- Board meeting, 20-12-2018
- Permanent representative, Vincent Verschraegen
2018
04-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
05-10
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)2 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)
2 facts ▸
- General meeting, 30-08-2017
- Auditor reappointment, Deloitte Bedrijfsrevisoren
13-09
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 44 days late
05-05
State Gazette act
Resignation: Jens Neuschaefer (manager)Appointments: Anthonius van 't Hullenaar (manager) and Maximilian von Wülfing (manager) · Permanent representative: Anthonius van 't Hullenaar · Mandate compensation8 facts ▸
State Gazette act
Resignation: Jens Neuschaefer (manager)
Appointments: Anthonius van 't Hullenaar (manager) and Maximilian von Wülfing (manager) · Permanent representative: Anthonius van 't Hullenaar · Mandate compensation8 facts ▸
- General meeting, 15-03-2017
- Director resignation, Jens Neuschaefer (manager)
- Director appointment, Anthonius van 't Hullenaar (manager)
- Director appointment, Maximilian von Wülfing (manager)
- Mandate compensation, Anthonius van 't Hullenaar
- Mandate compensation, Maximilian von Wülfing
- Board meeting, 15-03-2017
- Permanent representative, Anthonius van 't Hullenaar
24-01
State Gazette act
Resignation: Yves Brigode (manager)3 facts ▸
State Gazette act
Resignation: Yves Brigode (manager)
3 facts ▸
- General meeting, 05-01-2017
- Director resignation, Yves Brigode (manager)
- Board composition, Jens Neuschaefer (manager)
2016
15-09
State Gazette act
Appointment: Jens Neuschaefer (manager)Mandate compensation3 facts ▸
State Gazette act
Appointment: Jens Neuschaefer (manager)
Mandate compensation3 facts ▸
- General meeting, 08-08-2016
- Director appointment, Jens Neuschaefer (manager)
- Mandate compensation, Jens Neuschaefer
2015
09-09
State Gazette act
Resignation: Khadija Badli (manager)Appointment: Yves Brigode (manager) · Mandate compensation · Power of attorney6 facts ▸
State Gazette act
Resignation: Khadija Badli (manager)
Appointment: Yves Brigode (manager) · Mandate compensation · Power of attorney6 facts ▸
- General meeting, 20-08-2015
- Director resignation, Khadija Badli (manager)
- Director appointment, Yves Brigode (manager)
- Mandate compensation, Yves Brigode
- Power of attorney, Yves Brigode
- Power of attorney, Karen Laevaert
28-01
State Gazette act
Resignation: Gary Sphar (manager)Power of attorney3 facts ▸
State Gazette act
Resignation: Gary Sphar (manager)
Power of attorney3 facts ▸
- General meeting, 30-12-2014
- Director resignation, Gary Sphar (manager)
- Power of attorney, Karen Laevaert
2014
23-07
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)Power of attorney3 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)
Power of attorney3 facts ▸
- General meeting, 19-06-2014
- Auditor reappointment, Deloitte Bedrijfsrevisoren
- Power of attorney, Karen Laevaert
2013
30-12
State Gazette act
Resignation: Mylan BVBA (manager)Appointment: Khadija Badli (manager) · Mandate compensation4 facts ▸
State Gazette act
Resignation: Mylan BVBA (manager)
Appointment: Khadija Badli (manager) · Mandate compensation4 facts ▸
- General meeting, 11-12-2013
- Director resignation, Mylan BVBA (manager)
- Director appointment, Khadija Badli (manager)
- Mandate compensation, Khadija Badli
02-10
State Gazette act
Resignation: Pascale Engelen (manager)Appointment: Mylan BVBA (manager) · Mandate compensation4 facts ▸
State Gazette act
Resignation: Pascale Engelen (manager)
Appointment: Mylan BVBA (manager) · Mandate compensation4 facts ▸
- General meeting, 28-08-2013
- Director resignation, Pascale Engelen (manager)
- Director appointment, Mylan BVBA (manager)
- Mandate compensation, Mylan BVBA
10-01
State Gazette act
Resignation: Didier Barret (manager)Appointment: Gary Sphar (manager) · Mandate compensation4 facts ▸
State Gazette act
Resignation: Didier Barret (manager)
Appointment: Gary Sphar (manager) · Mandate compensation4 facts ▸
- General meeting, 20-12-2012
- Director resignation, Didier Barret (manager)
- Director appointment, Gary Sphar (manager)
- Mandate compensation, Gary Sphar
2012
01-02
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)3 facts ▸
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)
3 facts ▸
- Board meeting, 09-01-2012
- General meeting, 11-01-2012
- Auditor reappointment, Deloitte Bedrijfsrevisoren
2011
07-04
State Gazette act
Resignation: Heather Bresch (manager)2 facts ▸
State Gazette act
Resignation: Heather Bresch (manager)
2 facts ▸
- General meeting, 17-03-2011
- Director resignation, Heather Bresch (manager)
16-03
State Gazette act
Resignations: Seshan Srinivasan, Malik Rajiv and Bouldoires VincentAppointment: Pascale Engelen (manager) · Mandate compensation6 facts ▸
State Gazette act
Resignations: Seshan Srinivasan, Malik Rajiv and Bouldoires Vincent
Appointment: Pascale Engelen (manager) · Mandate compensation6 facts ▸
- General meeting, 21-02-2011
- Director resignation, Seshan Srinivasan (manager)
- Director resignation, Malik Rajiv (manager)
- Director resignation, Bouldoires Vincent (manager)
- Director appointment, Pascale Engelen (manager)
- Mandate compensation, Pascale Engelen
2010
20-10
State Gazette act
Permanent representative: V. BouldoiresResignation: Prasad Nimmagadda (director) · Power of attorney6 facts ▸
State Gazette act
Permanent representative: V. Bouldoires
Resignation: Prasad Nimmagadda (director) · Power of attorney6 facts ▸
- Board meeting, 20-05-2010
- Permanent representative, V. Bouldoires
- Director resignation, Prasad Nimmagadda (director)
- General meeting, 17-06-2010
- Director resignation, Prasad Nimmagadda (manager)
- Power of attorney, Karen Laevaert
25-02
State Gazette act
Appointments: Bouldoires Vincent Pierre, Bresch Heather Mangrin and 4 othersResignation: Docpharma (director) · Legal-form conversion · Capital11 facts ▸
State Gazette act
Appointments: Bouldoires Vincent Pierre, Bresch Heather Mangrin and 4 others
Resignation: Docpharma (director) · Legal-form conversion · Capital11 facts ▸
- General meeting, 27-01-2010
- Legal-form conversion, naamloze vennootschap -> besloten vennootschap met beperkte aansprakelijkheid
- Capital, €57.578.062,74
- Director appointment, Bouldoires Vincent Pierre (manager)
- Director appointment, Bresch Heather Mangrin (manager)
- Director appointment, Barret Didier Henri (manager)
- Director appointment, Seshan Srinivasan (manager)
- Director appointment, Nimmagadda Prasad (manager)
- Director appointment, Malik Rajiv (manager)
- Mandate compensation, Bouldoires Vincent Pierre
- Director resignation, Docpharma
20-01
State Gazette act
Statutes amendmentAccounting effect4 facts ▸
State Gazette act
Statutes amendment
Accounting effect4 facts ▸
- General meeting, 28-12-2009
- Statutes amendment
- Statutes amendment
- Accounting effect, 01-04-2009
08-01
State Gazette act
Registered officeRegistered-office move2 facts ▸
State Gazette act
Registered office
Registered-office move2 facts ▸
- Board meeting, 11-12-2009
- Registered-office move, Terhulpsesteenweg 6A, 1560 Hoeilaart
2009
10-08
State Gazette act
Appointment: Vincent Bouldoires (general manager)Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)4 facts ▸
State Gazette act
Appointment: Vincent Bouldoires (general manager)
Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)4 facts ▸
- Board meeting, 06-07-2009
- Director appointment, Vincent Bouldoires (general manager)
- General meeting, 20-07-2009
- Auditor reappointment, Deloitte Bedrijfsrevisoren
2007
26-02
State Gazette act
Resignations: C.S Murali, C Ramakrishna and Matrix Laboratories NVAppointments: Robert Coury, Edward Borkowski and Heather Bresch · Director discharge10 facts ▸
State Gazette act
Resignations: C.S Murali, C Ramakrishna and Matrix Laboratories NV
Appointments: Robert Coury, Edward Borkowski and Heather Bresch · Director discharge10 facts ▸
- General meeting, 08-02-2007
- Director resignation, C.S Murali (director)
- Director resignation, C Ramakrishna (director)
- Director resignation, Matrix Laboratories NV (director)
- Director discharge, C.S Murali
- Director discharge, C Ramakrishna
- Director discharge, Matrix Laboratories NV
- Director appointment, Robert Coury (director)
- Director appointment, Edward Borkowski (director)
- Director appointment, Heather Bresch (director)
2005
14-03
State Gazette act
Resignations: Etienne Lenoir (director) and Maarten Coolen (director)Appointment: Anthony Herbert Bloom (director) · Director discharge6 facts ▸
State Gazette act
Resignations: Etienne Lenoir (director) and Maarten Coolen (director)
Appointment: Anthony Herbert Bloom (director) · Director discharge6 facts ▸
- General meeting, 29-10-2004
- Director resignation, Etienne Lenoir (director)
- Director resignation, Maarten Coolen (director)
- Director discharge, Etienne Lenoir
- Director discharge, Maarten Coolen
- Director appointment, Anthony Herbert Bloom (director)
17-01
State Gazette act
Appointment: Van Rompay Management (afgevaardigd bestuurder)Permanent representative: Leon Van Rompay · Ratification4 facts ▸
State Gazette act
Appointment: Van Rompay Management (afgevaardigd bestuurder)
Permanent representative: Leon Van Rompay · Ratification4 facts ▸
- Board meeting, 21-12-2004
- Director appointment, Van Rompay Management (afgevaardigd bestuurder)
- Permanent representative, Leon Van Rompay
- Ratification, alle handelingen gesteld in de hoedanigheid van afgevaardigd bestuurder sinds 24 november 2003
2004
19-07
State Gazette act
Resignations & appointmentsStatutes amendment · Power of attorney4 facts ▸
State Gazette act
Resignations & appointments
Statutes amendment · Power of attorney4 facts ▸
- General meeting, 02-07-2004
- Statutes amendment
- Power of attorney, Leon Van Rompay
- Power of attorney, Stijn Van Rompay
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
30 of 30 acts read
Directors · office · real estate
Directors
2 directors, no change since 2025
Board 2
Tomasz Buczek
CurrentDirector · since 25-06-2025
Arun Narayan
CurrentDirector · since 26-11-2025
6 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Anthony Herbert Bloom
Not recently confirmedDirector · since 29-10-2004
Edward Borkowski
Not recently confirmedDirector · since 09-02-2007
Robert Coury
Not recently confirmedDirector · since 09-02-2007
Barret Didier Henri
Not recently confirmedManager · since 27-01-2010
Bouldoires Vincent Pierre
Not recently confirmedManager · since 27-01-2010
Bresch Heather Mangrin
Not recently confirmedManager · since 27-01-2010
Day-to-day management 1
Van Rompay Management
Not recently confirmedAfgevaardigd bestuurder · since 24-11-2003 · Legal entity · perm. rep.: Leon Van Rompay
Permanent representatives 1
Leon Van Rompay
Not recently confirmedPermanent representative · since 24-11-2003 · for Van Rompay Management
Statutory auditor 1
Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises
CurrentStatutory auditor · since 26-09-2008 · perm. rep.: Tom Renders
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Location & real-estate footprint
Registered office, Hoeilaart · 1 establishment unit since 1999
Ground area
5,791 m²
Building footprint
1,094 m²
Volume, LiDAR
11,847 m³
2 parcels, Flanders · tallest building 15.2 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Terhulpsesteenweg 6A, 1560 Hoeilaart
since 19992.103.154.988
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23033C0075/00L019 | Flanders | 3,821 m² | 1 · 921 m² | 14.7 m · 4 fl. |
| 23033C0073/00E009 | Flanders | 1,970 m² | 1 · 173 m² | 15.2 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
33 people since 2003, 10 in office
- Board
- Day-to-day management
- Statutory auditor
- Other function
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| Tomasz Buczek |
|
| Arun Narayan |
|
| Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises |
|
| Anthony Herbert Bloom |
|
| Edward Borkowski |
|
| Robert Coury |
|
| Barret Didier Henri |
|
| Bouldoires Vincent Pierre |
|
| Bresch Heather Mangrin |
|
| Van Rompay Management |
|
| Matthew Salzmann |
|
| Vincent Verschraegen |
|
| Luis Birbuet |
|
| José Cotarelo |
|
| Anthonius van 't Hullenaar |
|
| Maximilian von Wülfing |
|
| Jens Neuschaefer |
|
| Yves Brigode |
|
| Khadija Badli |
|
| Gary Sphar |
|
| Mylan BVBA |
|
| Pascale Engelen |
|
| Didier Barret |
|
| Heather Bresch |
|
| Bouldoires Vincent |
|
| Malik Rajiv |
|
| Seshan Srinivasan |
|
| Nimmagadda Prasad |
|
| C Ramakrishna |
|
| C.S Murali |
|
| Matrix Laboratories NV |
|
| Etienne Lenoir |
|
| Maarten Coolen |
|
Articles of association
Purpose
Alle industrieie, commerciele verrichtingen met betrekking tot de chemische, farmaceutische, dieetvoeding- en cosmeticaproducten; alle industriële, commerciele verrichtingen met…
Full purpose
Alle industrieie, commerciele verrichtingen met betrekking tot de chemische, farmaceutische, dieetvoeding- en cosmeticaproducten; alle industriële, commerciele verrichtingen met betrekking tot producten die dienstig zijn in de medische sector; vertegenwoordiging en verkoop voor derden van alierlei materialen, toestellen en diensten, vertegenwoordiging, aan- en verkoop, im- en export, verhuur en instaliatie van medische apparatuur, pacemakers, medische en paramedische materialen en alle randapparatuur en toebehoren daarmee gepaard gaande, alsmede het onderhoud ervan; alle verrichtingen van commerciele, industritle, onroerende, roerende en financiele aard, die rechtstreeks met dit doel verwant of verknocht zijn, of de verwezenlijking ervan kunnen bevorderen; de vestiging en de uitbating van brevetten, merken, licenties en octrooien met betrekking tot de hierboven vermelde producten; de uitbating, de concessie, aankoop, verkoop en veruuwr van de lokalen of enroerende goederen waarin de bovenvermelde activiteiten kunnen worden gerealiscerd en alle toebehoren; belangenbehartiging t.a.v, prijzen en terugbetalingen t.o.v. diverse administraties en belangengroeperingen in de farnaceutische sector; de vennootschap mag haar doel verwezenlijken in Belgie zowel als in het buitenland, op alle wijzen en manieren die zij het best geschikt acht. Zij mag eveneens belangen verwerven bij wijze van inbreng, inschrijving of anderszins, in alle ondememingen of vennootschappen die een gelijkaardig analoog of aanverwant doel nastreven of wier doel van die aard is dat van die vennootschap te benaderen.
Structure & network
Owners and holdings
1 owner · 1 holdingChain of control
- Viatris GX
- DOCPHARMA
Highest known parent: Viatris GX. The sources do not say who stands above it.
Owners 1
- Viatris GXparent100%
Holdings 1
-
99.99%
According to the 2025 annual accounts of DOCPHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
2 current directorsThe group is listed under Ownership & control below; here you explore it as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Ownership & control
2 board mandatesBoard mandates of this companythis company sits on their board2
1 location
1 location
Capital and shareholders
Capital over the years
- 25-02-2010 Capital stated in the act · 57,578,062.74 EUR · 6,297,570 shares
Identification & contact
Identification
Legal formPrivate limited company
Founded05-03-1999
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID
0208:0465350075
Also
9925:BE0465350075
Registered
20-11-2020
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.